Navigation Links
AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain
Date:6/29/2009

>

Study investigator, anesthesiologist Dr. Neil Singla, CEO of Lotus Clinical Research Inc., Pasadena, CA, stated, "The ARX-01 product has the potential to offer a major advance in the management of inpatient acute pain, liberating patients from the IV connection to a PCA pump, while still providing effective pain control appropriate even for patients who are restricted from oral medication. Patients appear to tolerate the Sufentanil NanoTabs well, and following the end of the 12-hour study period when they were switched to IV PCA morphine, many requested that they be returned to study drug. To me, these patients' requests are as demonstrative as any more quantitative endpoint of the product's advantages from the patient perspective."

The current data support the previously reported positive results for ARX-01 from the first Phase 2 study which evaluated the safety and efficacy of ARX-01 Sufentanil NanoTabs in patients undergoing elective unilateral knee replacement surgery. Additionally, an open-label Phase 2 study is currently ongoing with the primary objective of assessing the functionality of the handheld device component of the ARX-01 Sufentanil NanoTab PCA System in patients undergoing unilateral knee replacement surgery.

AcelRx Chief Medical Officer, Pamela Palmer, M.D., Ph.D., commented, "The Phase 2 results from both knee replacement and major abdominal surgery studies demonstrate that a wide variety of patients experiencing moderate-to-severe post-operative pain are able to achieve significant pain relief with our non-invasive approach to patient-controlled analgesia utilizing sublingual Sufentanil NanoTabs. We are pleased with the efficacy results, as well as with the overall side-effect profile of ARX-01 which was indistinguishable from placebo in both studies."

About Acute Post-Operative Pain

Annually, approximately 8 million patients in the U.S. receive intravenous (IV) patient-cont
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. AcelRx Pharmaceuticals Reports Positive Results from a Clinical Trial of Sublingual Sufentanil/Triazolam NanoTab(TM) Combination (ARX-03) in Treating Procedural Pain and Anxiety
2. AcelRx Initiates a Phase 2 Study to Evaluate Functionality of Its ARX-01 Sufentanil NanoTab PCA System
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...wire-USNewswire/ -- ,, Beverage Can Stay-Tabs...innati Children,s Hospital Medical Center reports ...tion risk. In the 1970s, U.S. manufacturers switch...out pull-tabs. The new study found 19 cases of sta...ong teenagers. Further, the study found that most ...
(Date:11/29/2009)...swire/ -- A large proportion of patients who under...ve unindicated and unnecessary additional image ac... exposure, according to a study presented today at... North America (RSNA). ,, "It is the responsibi...ation to ensure that the dosage is as low as reaso...
(Date:11/29/2009)...swire/ -- FUJIFILM Medical Systems USA, Inc. is pl...flat panel DR cassette, at the 2009 Radiological S...eal for any clinical environment, FDR D-EVO uses a...with Fujifilm,s trademark image quality and outsta...r users to transition to DR without modification t...
Breaking Medicine Technology:Monday, Nov. 30: News From the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago 2Monday, Nov. 30: News From the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago 3Unindicated CT Series Result in Unnecessary Radiation Exposure for Patients 2Unindicated CT Series Result in Unnecessary Radiation Exposure for Patients 3FUJIFILM's DR Cassette Makes World Debut 2Give Blood Today for Community Preparedness 55107 1Give Blood Today for Community Preparedness 55107 2Give Blood Today for Community Preparedness 55107 3QImaging Introduces EXi Aqua 26amp 3B 238482 3B Microscopy Camera for Bio Imaging 13653 1QImaging Introduces EXi Aqua 26amp 3B 238482 3B Microscopy Camera for Bio Imaging 13653 2QImaging Introduces EXi Aqua 26amp 3B 238482 3B Microscopy Camera for Bio Imaging 13653 3Battling Inflammation Through Food an Emerging Field 55102 1Battling Inflammation Through Food an Emerging Field 55102 2
... from,Schering-Plough, Roche today affirmed the va...nation with ribavirin as the market-leading,treatm...tates and globally.,Despite clear biases in the de... patients taking Peg-Intron(TM) (peginterferon alf...eduction protocol - the study results have,shown t...
...eased to,announce that it has been granted an Inte...rom Australia, China and India. The approved paten...Method of use for Gut-based,Therapy," protects the...probiotic product formulation (Kibow Biotics(R)) w...veral nitrogenous waste metabolites that,accumulat...
Other Medicine Technology:Roche responds to announcement of 'IDEAL' hepatitis C trial results 2Roche responds to announcement of 'IDEAL' hepatitis C trial results 3Roche responds to announcement of 'IDEAL' hepatitis C trial results 4Roche responds to announcement of 'IDEAL' hepatitis C trial results 5Roche responds to announcement of 'IDEAL' hepatitis C trial results 6Roche responds to announcement of 'IDEAL' hepatitis C trial results 7Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure 2Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure 3
(Date:11/30/2009)... House and Senate bills stack up , , MON...form bills moving through the U.S. Congress differ...dramatic reduction in the number of uninsured Amer...epresentatives earlier this month would expand cov...eparing to debate a proposal to expand coverage to...
(Date:11/30/2009)... APR Energy (APR) recently donated medi... La Esperanza during a Free General Health Campaig...eranza, Caja Municipal and Huggies. The donation w...e communities where they build, own and operate pl...s targeted at benefiting the areas surrounding APR...
(Date:11/30/2009)... How about a stocking stuffer that save...e,s Super-Reflective POP BANDS® , Pet Collars...ive, unique, and fun gifts that make a difference....vember 30, 2009 -- How would you like to give a gi...all year?, , , , ,Vedante,s super-reflective POP ...
(Date:11/30/2009)... According to Steven McConnell, DDS, te...ring flu season is a good idea, but brushing their...tually coming down with a virus. , ...o the California Dental Hygienists’ Associat...etween oral health and flu prevention because the ...
(Date:11/30/2009)... Firm uses Staten Island courtroom to r...endants were 100% responsible for client’s a...s Nexis) November 30, 2009 -- A Staten Island, N.Y... union paperhanger who was injured at a New York C...mondi v. J.T. Magen Construction Company et al (In...
Breaking Medicine News(10 mins):Health News:Health Reform: What's in It for You? 2Health News:Health Reform: What's in It for You? 3Health News:APR Energy Donates Medicine and Medical Services to Community of La Esperanza 2Health News:Fun and Fashionable Holiday Gifts that Save Lives 2Health News:Fun and Fashionable Holiday Gifts that Save Lives 3Health News:Fun and Fashionable Holiday Gifts that Save Lives 4Health News:Tips on Decreasing Susceptibility to the H1N1 Virus - Optimum Oral Hygiene Can Prevent Flu 2Health News:Tips on Decreasing Susceptibility to the H1N1 Virus - Optimum Oral Hygiene Can Prevent Flu 3Health News:Tips on Decreasing Susceptibility to the H1N1 Virus - Optimum Oral Hygiene Can Prevent Flu 4Health News:Raphaelson & Levine Secures $1.1 Million Verdict for Victim of New York Construction Accident 2
...ad discovered a changed version of dopamine// tran...ns that may be associated with substance abuse or ... Dopamine is a protein produced in the hypoth...l and central nervous system regulations. The dopa...
...nformation about how neuro degenerative// diseases...d. Researchers at the Rocky Mountain Laborato...ovel insights into how abnormal prion proteins wor...did not show the symptoms of scrapie disease when ...
...f vitamin B may be at less risk from colorectal// ... of alcohol along with vitamin B may have even red...er of the colorectal happens when there is growth ...te intake of dietary vitamin B is at fault for the...
...ugs like warfarin may react differently to the dru...e population of the world takes anti clotting medi...ajor surgery to check harmful clotting of blood. H...rug. A little change in dose often may result in m...
...affected by factors like stress, mood, //anxiety a...rnal of the American Dietetic Association. Di... the fetus and needs to contain the food elements ...re of one kind of foods, like carbohydrates etc. T...
...) may lead to different genetic response// to the ...in life. The drug DES was prescribed to women...8 to 1971. Research says that daughters of women w...vaginal and cervical cancer called clear-cell aden...
Other Medicine News:
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
Medicine Products: